P-BCMA-ALLO1

P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma (MM)

What's the purpose of the trial?

Phase 1/1b study comprised of open-label, dose escalation, multiple cohorts of P-BCMA-ALLO1 allogeneic T stem cell memory (Tscm) CAR-T cells in subjects with relapsed / refractory Multiple Myeloma (RRMM).

Trial status

Accepting patients

Phase
Phase 1
Enrollment
231
Last Updated
2 weeks ago
Am I Eligible

Participating Centers

There are 11 centers participating in this trial. Enter a location below to find the closest center.

Experimental Treatments

Learn more about the experimental treatments being evaluated in this clinical trial.

  • P-BCMA-101
  • Rimiducid

Arms / Cohorts

Explore eligibility, treatments and learn more about potential cohorts.

Accepting patients

P-BCMA-ALLO1 CAR-T cells (Arm S)

Accepting patients

P-BCMA-ALLO1 CAR-T cells (Arm F)

Accepting patients

P-BCMA-ALLO1 CAR-T cells (Arm N)

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 828-2206

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.